The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available.

This guideline was previously called autism diagnosis in children and young people: recognition, referral and diagnosis of children and young people on the autism spectrum. We will regularly review their potential impact on our autism guidelines. We are monitoring important initiatives in progress that may affect future service delivery.

We checked this guideline in June 2021 and found no new evidence that affects the recommendations. Autistic children and young people, children and young people who may be autistic, and their families and carers.information and support for families and carers.communicating the results from the autism diagnostic assessment.autism diagnostic assessment for children and young people.referring children and young people to the autism team.recognising children and young people with possible autism.local pathway for recognition, referral and diagnostic assessment of possible autism.This guideline includes recommendations on: This guideline should be used alongside our guidelines on autism spectrum disorder in under 19s: support and management and autism spectrum disorder in adults: diagnosis and management. In December 2017, we reviewed the evidence and added ADHD as a factor associated with an increased prevalence of autism and changed references from DSM-4 to DSM-5. It aims to improve the experience of children, young people and those who care for them. This guideline covers recognising and diagnosing autism spectrum disorder in children and young people from birth up to 19 years.

Dsm 5 asd citation